Radiomics risk score may be a potential imaging biomarker for predicting survival in isocitrate dehydrogenase wild-type lower-grade gliomas
This study aimed to evaluate whether radiomics from magnetic resonance imaging (MRI) would allow for the prediction of the overall survival in patients with isocitrate dehydrogenase wild-type (IDHwt) lower-grade gliomas. The authors of this study also investigated the added prognostic value of radiomics over clinical features. The authors found that radiomics has the potential for noninvasive risk stratification and can